SUPN logo

Supernus Pharmaceuticals (SUPN) Working capital

annual working capital:

$393.67M+$190.76M(+94.01%)
December 31, 2024

Summary

  • As of today (July 1, 2025), SUPN annual working capital is $393.67 million, with the most recent change of +$190.76 million (+94.01%) on December 31, 2024.
  • During the last 3 years, SUPN annual working capital has risen by +$107.46 million (+37.55%).
  • SUPN annual working capital is now at all-time high.

Performance

SUPN Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

quarterly working capital:

$405.81M+$12.14M(+3.08%)
March 31, 2025

Summary

  • As of today (July 1, 2025), SUPN quarterly working capital is $405.81 million, with the most recent change of +$12.14 million (+3.08%) on March 31, 2025.
  • Over the past year, SUPN quarterly working capital has increased by +$176.04 million (+76.62%).
  • SUPN quarterly working capital is now -12.57% below its all-time high of $464.16 million, reached on March 31, 2018.

Performance

SUPN quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSUPNbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

SUPN Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+94.0%+76.6%
3 y3 years+37.5%+42.9%
5 y5 years+26.1%+4.4%

SUPN Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+752.2%at high+467.5%
5 y5-yearat high+752.2%-6.4%+467.5%
alltimeall timeat high+1499.8%-12.6%+467.5%

SUPN Working capital History

DateAnnualQuarterly
Mar 2025
-
$405.81M(+3.1%)
Dec 2024
$393.67M(+94.0%)
$393.67M(+13.0%)
Sep 2024
-
$348.50M(+23.4%)
Jun 2024
-
$282.35M(+22.9%)
Mar 2024
-
$229.77M(+13.2%)
Dec 2023
$202.92M(+339.3%)
$202.92M(+25.4%)
Sep 2023
-
$161.83M(-5.3%)
Jun 2023
-
$170.95M(+12.6%)
Mar 2023
-
$151.79M(+228.6%)
Dec 2022
$46.19M(-83.9%)
$46.19M(-174.4%)
Sep 2022
-
-$62.10M(-43.8%)
Jun 2022
-
-$110.42M(-138.9%)
Mar 2022
-
$283.96M(-0.8%)
Dec 2021
$286.21M(-25.7%)
$286.21M(-34.0%)
Sep 2021
-
$433.66M(+21.9%)
Jun 2021
-
$355.80M(+3.1%)
Mar 2021
-
$345.21M(-10.4%)
Dec 2020
$385.31M(+23.5%)
$385.31M(+52.7%)
Sep 2020
-
$252.41M(-12.3%)
Jun 2020
-
$287.88M(-25.9%)
Mar 2020
-
$388.71M(+24.6%)
Dec 2019
$312.06M(-6.0%)
$312.06M(+12.5%)
Sep 2019
-
$277.37M(+12.3%)
Jun 2019
-
$246.94M(-7.9%)
Mar 2019
-
$268.26M(-19.2%)
Dec 2018
$332.13M(+215.0%)
$332.13M(+31.7%)
Sep 2018
-
$252.21M(+39.7%)
Jun 2018
-
$180.58M(-61.1%)
Mar 2018
-
$464.16M(+340.2%)
DateAnnualQuarterly
Dec 2017
$105.45M(+49.2%)
$105.45M(+22.1%)
Sep 2017
-
$86.37M(+8.0%)
Jun 2017
-
$79.97M(+18.0%)
Mar 2017
-
$67.75M(-4.1%)
Dec 2016
$70.66M(+44.2%)
$70.66M(+6.2%)
Sep 2016
-
$66.56M(+37.0%)
Jun 2016
-
$48.57M(+21.9%)
Mar 2016
-
$39.83M(-18.7%)
Dec 2015
$49.01M(-39.2%)
$49.01M(-17.5%)
Sep 2015
-
$59.42M(-14.3%)
Jun 2015
-
$69.33M(-7.1%)
Mar 2015
-
$74.65M(-7.4%)
Dec 2014
$80.60M(+13.9%)
$80.60M(-0.3%)
Sep 2014
-
$80.84M(+53.1%)
Jun 2014
-
$52.79M(-0.1%)
Mar 2014
-
$52.83M(-25.3%)
Dec 2013
$70.76M(+3.3%)
$70.76M(-9.0%)
Sep 2013
-
$77.79M(-17.8%)
Jun 2013
-
$94.59M(+91.8%)
Mar 2013
-
$49.32M(-28.0%)
Dec 2012
$68.48M(+123.6%)
$68.48M(+78.8%)
Sep 2012
-
$38.30M(-31.5%)
Jun 2012
-
$55.92M(+202.2%)
Mar 2012
-
$18.50M(-39.6%)
Dec 2011
$30.63M(+24.5%)
$30.63M(+264.6%)
Sep 2011
-
$8.40M(-65.9%)
Dec 2010
$24.61M(-60.8%)
$24.61M(-27.3%)
Sep 2010
-
$33.84M(-46.2%)
Dec 2009
$62.85M(+2.7%)
$62.85M
Dec 2008
$61.18M
-

FAQ

  • What is Supernus Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals annual working capital year-on-year change?
  • What is Supernus Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for Supernus Pharmaceuticals?
  • What is Supernus Pharmaceuticals quarterly working capital year-on-year change?

What is Supernus Pharmaceuticals annual working capital?

The current annual working capital of SUPN is $393.67M

What is the all time high annual working capital for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high annual working capital is $393.67M

What is Supernus Pharmaceuticals annual working capital year-on-year change?

Over the past year, SUPN annual working capital has changed by +$190.76M (+94.01%)

What is Supernus Pharmaceuticals quarterly working capital?

The current quarterly working capital of SUPN is $405.81M

What is the all time high quarterly working capital for Supernus Pharmaceuticals?

Supernus Pharmaceuticals all-time high quarterly working capital is $464.16M

What is Supernus Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, SUPN quarterly working capital has changed by +$176.04M (+76.62%)
On this page